Edwards Lifesciences Corporatio

$84.74

Name : Edwards Lifesciences Corporatio

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $49,750,855,680.00

EPSttm : 2.28

Edwards Lifesciences Corporatio

$84.74

1.81%

$1.56

Float Short %

1.6

Margin Of Safety %

-10

Put/Call OI Ratio

0.87

EPS Next Q Diff

0.01

EPS Last/This Y

-4.4

EPS This/Next Y

0.28

Price

84.71

Target Price

94.81

Analyst Recom

1.89

Performance Q

7.36

Relative Volume

0.83

Beta

0.96

Ticker: EW

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	EW	75.29	1.08	0.05	83418
2025-10-21	EW	76.01	0.70	0.70	106836
2025-10-22	EW	76.83	0.71	0.62	109268
2025-10-23	EW	76.54	0.71	0.71	118243
2025-10-24	EW	76.1	0.72	1.48	119546
2025-10-27	EW	80.83	0.75	0.10	123225
2025-10-28	EW	82.21	0.72	0.12	125409
2025-10-29	EW	82.68	0.75	0.84	123017
2025-10-30	EW	83.45	0.78	0.81	122931
2025-10-31	EW	82.43	0.78	0.32	125798
2025-11-03	EW	83.07	0.77	0.34	126467
2025-11-04	EW	84.14	0.77	0.91	126829
2025-11-05	EW	82.83	0.77	0.12	127708
2025-11-06	EW	82.45	0.75	0.09	129892
2025-11-07	EW	83.39	0.79	0.42	126631
2025-11-10	EW	84.08	0.81	1.03	126423
2025-11-11	EW	85.18	0.81	6.29	127055
2025-11-12	EW	85.56	0.85	1.63	131030
2025-11-13	EW	86.15	0.86	1.04	131829
2025-11-14	EW	86.38	0.87	1.02	132691
2025-11-17	EW	84.75	0.87	1.21	133076
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	EW	75.28	-11.7	125.1	2.51
2025-10-21	EW	76.00	-11.7	126.9	2.51
2025-10-22	EW	76.84	-11.7	129.5	2.51
2025-10-23	EW	76.55	-11.7	101.4	2.51
2025-10-24	EW	76.12	-11.7	98.3	2.51
2025-10-27	EW	80.84	-11.7	228.9	2.51
2025-10-28	EW	82.19	-11.7	141.2	2.51
2025-10-29	EW	82.70	-11.7	120.6	2.51
2025-10-30	EW	83.48	-11.7	127.0	2.51
2025-10-31	EW	82.45	-11.5	85.1	2.51
2025-11-03	EW	83.02	-11.5	121.9	2.51
2025-11-04	EW	84.14	4.3	133.4	2.58
2025-11-05	EW	82.83	4.3	78.7	2.58
2025-11-06	EW	82.43	4.5	89.4	2.58
2025-11-07	EW	83.39	4.5	89.9	2.58
2025-11-10	EW	84.08	4.5	83.7	2.58
2025-11-11	EW	85.16	4.6	92.4	2.58
2025-11-12	EW	85.54	4.6	76.6	2.58
2025-11-13	EW	86.11	4.6	79.9	2.58
2025-11-14	EW	86.29	4.6	72.0	2.58
2025-11-17	EW	84.71	4.6	33.0	2.58
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	EW	-0.52	-0.87	1.30
2025-10-21	EW	-0.52	-0.87	1.30
2025-10-22	EW	-0.52	-0.87	1.30
2025-10-23	EW	-0.52	-0.87	1.30
2025-10-24	EW	-0.52	-0.87	1.30
2025-10-27	EW	-0.52	-3.16	1.35
2025-10-28	EW	-0.52	-3.16	1.35
2025-10-29	EW	-0.52	-3.16	1.35
2025-10-30	EW	-0.52	-3.16	1.35
2025-10-31	EW	-0.52	-3.16	1.35
2025-11-03	EW	-0.52	-2.91	1.35
2025-11-04	EW	-0.52	-2.91	1.35
2025-11-05	EW	-0.52	-2.91	1.35
2025-11-06	EW	-0.52	-2.91	1.35
2025-11-07	EW	-0.48	-2.91	1.35
2025-11-10	EW	-0.38	-2.52	1.37
2025-11-11	EW	-0.49	-2.52	1.37
2025-11-12	EW	-0.49	-2.52	1.60
2025-11-13	EW	-0.49	-2.52	1.60
2025-11-14	EW	-0.49	-2.52	1.60
2025-11-17	EW	-0.49	-0.04	1.60
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.67

Avg. EPS Est. Current Quarter

0.62

Avg. EPS Est. Next Quarter

0.68

Insider Transactions

-0.49

Institutional Transactions

-0.04

Beta

0.96

Average Sales Estimate Current Quarter

1540

Average Sales Estimate Next Quarter

1569

Fair Value

76.19

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

35.7

Max Drawdown 5-Year %

-54.3

Target Price

94.81

P/E

36.07

Forward P/E

29.49

PEG

3.67

P/S

8.36

P/B

4.82

P/Free Cash Flow

61.15

EPS

2.35

Average EPS Est. Cur. Y

2.58

EPS Next Y. (Est.)

2.86

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

23.48

Relative Volume

0.83

Return on Equity vs Sector %

-13.5

Return on Equity vs Industry %

-4.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.07

EBIT Estimation

Edwards Lifesciences Corporatio

Sector: Healthcare

Industry: Medical Devices

Employees: 15800

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

stock quote shares EW – Edwards Lifesciences Corporation Stock Price stock today

news today EW – Edwards Lifesciences Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch EW – Edwards Lifesciences Corporation yahoo finance google finance

stock history EW – Edwards Lifesciences Corporation invest stock market

stock prices EW premarket after hours

ticker EW fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: EW

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y